J. Bardelas

SQ house dust mite sublingual immunotherapy tablet subgroup efficacy and local application site reaction duration.

D. Bernstein, H. Nelson, H. Nolte, 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Immunogenicity and safety of omalizumab in pre-filled syringes in patients with allergic (IgE-mediated) asthma

P. D’Andrea, G. Peachey, M. Blogg, 2014, Current medical research and opinion.

A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice

D. Bernstein, H. Nolte, A. Kaur, 2017, Postgraduate medicine.

Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies.

J. Bousquet, M. Malice, T. Reiss, 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

A 26-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Effect of Omalizumab on Asthma Control in Patients with Persistent Allergic Asthma

F. Kianifard, Xiangyi Meng, M. Figliomeni, 2012, The Journal of asthma : official journal of the Association for the Care of Asthma.

A Preference Evaluation Study Comparing the Sensory Attributes of Mometasone Furoate and Fluticasone Propionate Nasal Sprays by Patients with Allergic Rhinitis

E. Meltzer, H. Kaiser, A. Goldsobel, 2005, Treatments in respiratory medicine.